ATNF - 180 Life Sciences Corp.
1.08
-0.100 -9.259%
Share volume: 52,620
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.18
-0.10
-0.08%
View ratios
Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
Report Date | 05-15-2024 | 08-15-2023 | 11-09-2023 | 11-14-2024 | 05-15-2024 | 08-12-2024 | 11-14-2024 | |
Total revenue | -11.556 K | -11.606 K | -11.634 K | 189.474 K | 1.023 M | 1.701 M | 105.090 K | |
Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Operating expenses | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Selling general and admin | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Total expenses | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Operating income | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Ebit | -4.815 M | -3.695 M | -12.613 M | -1.229 M | -1.070 M | 11.532 K | -836.720 K | |
Pretax income | -4.762 M | -3.680 M | -12.611 M | -1.231 M | -1.070 M | 11.781 K | -836.720 K | |
-22.72% | 242.67% | -90.23% | -13.13% | -101.10% | -7,202.28% | |||
Income tax | 0.000 | 0.000 | -2.345 M | -4.389 K | 0.000 | 0.000 | 0.000 | |
Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income | -4.762 M | -3.680 M | -10.266 M | -1.227 M | -1.070 M | 11.781 K | -836.720 K | |
22.72% | -178.95% | 88.05% | 12.82% | 101.10% | -7,202.28% |